• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 4. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines

Professional Introduction to cis-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrole (CAS No. 1468-87-7)

cis-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrole, identified by the chemical identifier CAS No. 1468-87-7, is a significant heterocyclic compound that has garnered considerable attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the pyrrole derivatives family, characterized by its complex ring structure and potential biological activities. The molecular framework of cis-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrole consists of a cyclopentane ring fused with a pyrrole moiety in a cis configuration, which contributes to its unique electronic and steric properties.

The structural peculiarities of cis-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrole make it a versatile scaffold for drug discovery and development. Its rigid bicyclic system provides a stable platform for further functionalization, enabling the synthesis of various analogs with tailored biological profiles. In recent years, this compound has been extensively studied for its potential applications in treating neurological disorders and cancer. The presence of multiple chiral centers in its structure allows for the exploration of stereochemistry-dependent biological activities.

Recent advancements in computational chemistry and molecular modeling have facilitated a deeper understanding of the interactions between cis-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrole and biological targets. Studies have demonstrated that this compound can interact with specific proteins and enzymes involved in disease pathways. For instance, research indicates that derivatives of cis-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrole exhibit inhibitory effects on kinases and other enzymes implicated in tumor growth and progression. These findings have opened new avenues for developing novel therapeutic agents.

The pharmacological properties of cis-1,2,3，3a，4，5，6，6a-octahydrocyclopenta[c]pyrrole have also been explored in preclinical studies. Researchers have synthesized several derivatives to evaluate their efficacy and safety profiles in vitro and in vivo. Preliminary results suggest that certain analogs demonstrate promising anti-inflammatory and neuroprotective effects. These findings are particularly intriguing given the growing demand for drugs that target chronic inflammatory conditions and neurodegenerative diseases.

One of the most compelling aspects of cis-1，2，3，3a，4，5，6，6a-octahydrocyclopenta[c]pyrrole is its potential for modulating biological pathways through selective binding to target molecules. The compound’s ability to interact with specific receptors or enzymes without significant off-target effects is crucial for developing drugs with high efficacy and low toxicity. Ongoing research aims to optimize the structure-activity relationships (SAR) of this scaffold to enhance its pharmacological properties further.

The synthesis of cis-1，2，3，3a，4，5，6，6a-octahydrocyclopenta[c]pyrrole has been refined through various synthetic methodologies to improve yield and purity. Modern techniques such as asymmetric synthesis have enabled the production of enantiomerically pure forms of this compound. These advancements are essential for evaluating the stereochemical dependence of its biological activities accurately.

In conclusion,cis-1，2?3，3a，4，5?6，6a-octahydrocyclopenta[c]pyrrole (CAS No. 1468-87-7) represents a valuable scaffold for pharmaceutical innovation. Its unique structural features and promising biological activities make it a compelling candidate for further development into novel therapeutic agents. As research continues to uncover new insights into its pharmacological properties,cis-1，2?3，3a，4?5，6?6a-octahydrocyclopenta[c]pyrrole is poised to play an increasingly important role in addressing unmet medical needs.

• 112626-50-3(octahydrocyclopenta[c]pyrrole hydrochloride)
• 21250-89-5(1H,4H-3a,6a-Propanocyclopenta[c]pyrrole, tetrahydro- (8CI,9CI))
• 1420816-50-7(2-Azaspiro[4.4]nonan-7-ylmethanamine)
• 284-11-7(3-Azabicyclo[4.2.1]nonane)
• 1037834-39-1((3aR,6aS)-Octahydrocyclopenta[c]pyrrole)
• 36170-23-7(4-azatricyclo5.2.1.0^{2,6}decane)
• 5661-03-0(1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrole)
• 175-94-0(2-Azaspiro[4.4]nonane)
• 1420894-51-4(N-Methyl-2-(pyrrolidin-3-yl)ethanamine)
• 16160-75-1(4,7-Methano-1H-isoindole,octahydro-, (3aa,4b,7b,7aa)- (9CI))